Trexquant Investment LP raised its stake in Spok Holdings, Inc. (NASDAQ:SPOK - Free Report) by 49.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 106,467 shares of the Wireless communications provider's stock after buying an additional 35,401 shares during the quarter. Trexquant Investment LP owned about 0.53% of Spok worth $1,709,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Geode Capital Management LLC raised its holdings in shares of Spok by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 514,427 shares of the Wireless communications provider's stock worth $8,258,000 after acquiring an additional 6,591 shares during the period. State Street Corp increased its holdings in Spok by 3.1% during the 3rd quarter. State Street Corp now owns 415,876 shares of the Wireless communications provider's stock worth $6,263,000 after purchasing an additional 12,467 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Spok by 7.6% in the 4th quarter. JPMorgan Chase & Co. now owns 213,575 shares of the Wireless communications provider's stock valued at $3,428,000 after purchasing an additional 15,156 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Spok by 67.9% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 110,997 shares of the Wireless communications provider's stock valued at $1,782,000 after purchasing an additional 44,896 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Spok by 133.9% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 105,241 shares of the Wireless communications provider's stock worth $1,689,000 after buying an additional 60,256 shares during the period. Institutional investors own 50.81% of the company's stock.
Spok Trading Up 1.0 %
Shares of Spok stock traded up $0.14 during trading hours on Monday, reaching $15.27. 13,838 shares of the company's stock were exchanged, compared to its average volume of 118,694. The stock has a market cap of $311.88 million, a P/E ratio of 20.92 and a beta of 0.40. The company has a 50 day moving average of $16.23 and a two-hundred day moving average of $15.99. Spok Holdings, Inc. has a fifty-two week low of $13.24 and a fifty-two week high of $17.96.
Spok (NASDAQ:SPOK - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The Wireless communications provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). Spok had a net margin of 10.66% and a return on equity of 9.20%. The company had revenue of $33.89 million during the quarter, compared to the consensus estimate of $35.50 million. As a group, analysts expect that Spok Holdings, Inc. will post 0.76 earnings per share for the current fiscal year.
Spok Cuts Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Friday, March 14th were given a $0.3125 dividend. This represents a $1.25 dividend on an annualized basis and a dividend yield of 8.18%. The ex-dividend date was Friday, March 14th. Spok's dividend payout ratio (DPR) is presently 168.92%.
Analyst Ratings Changes
SPOK has been the topic of a number of recent research reports. StockNews.com raised Spok from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, April 8th. B. Riley upgraded shares of Spok from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $15.00 to $20.00 in a report on Thursday, February 27th.
Check Out Our Latest Analysis on SPOK
About Spok
(
Free Report)
Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.
Recommended Stories

Before you consider Spok, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spok wasn't on the list.
While Spok currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.